Live Vaccination with Blood-Stage <i>Plasmodium yoelii</i> 17XNL Prevents the Development of Experimental Cerebral Malaria
In our work, we aim to develop a malaria vaccine with cross-strain (-species) protection. C57BL/6 mice infected with the <i>P. berghei</i> ANKA strain (PbA) develop experimental cerebral malaria (ECM). In contrast, ECM development is inhibited in infected mice depleted of T cells. The cl...
Main Authors: | Takashi Imai, Ha Ngo-Thanh, Kazutomo Suzue, Aoi Shimo, Akihiro Nakamura, Yutaka Horiuchi, Hajime Hisaeda, Takashi Murakami |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/5/762 |
Similar Items
-
Potential and Limitations of Cross-Protective Vaccine against Malaria by Blood-Stage Naturally Attenuated Parasite
by: Takashi Imai, et al.
Published: (2020-07-01) -
Cytotoxic activities of CD8+ T cells collaborate with macrophages to protect against blood-stage murine malaria
by: Takashi Imai, et al.
Published: (2015-03-01) -
Standard Selection Treatments with Sulfadiazine Limit Plasmodium yoelii Host-to-Vector Transmission
by: Kelly T. Rios, et al.
Published: (2022-06-01) -
The acid ceramidase/ceramide axis controls parasitemia in Plasmodium yoelii-infected mice by regulating erythropoiesis
by: Anne Günther, et al.
Published: (2022-09-01) -
Effect of Etanercept on <i>Plasmodium yoelii</i> MDR-Induced Liver Lipid Infiltration
by: Bhavana Singh Chauhan, et al.
Published: (2022-11-01)